BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005

BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005

No trades
See on Supercharts

BIIB fundamentals

An in-depth look to BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 operating, investing, and financing activities

BIIB free cash flow for Q2 25 is 152.91 B ARS. For 2024, BIIB free cash flow was 2.49 T ARS and operating cash flow was 2.63 T ARS.

Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: ARS
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
TTM
Free cash flowYoY growth